Patrick Safo, MD
Dermatology · Stevens Point, WINPI 1104088202
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $37,849 of the $52,834 with a category attached, or 71.6%. 25 manufacturers reported payments, led by Bristol Myers Squibb at 54.1% of the total. Reporting peaked in 2019 at $28,797 and has fallen 96.9% since, to $903 in 2025. Among dermatology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $224.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$29K
- Janssen Scientific Affairs, LLC$12K
- Amgen$8K
- Johnson & Johnson$2K
- AbbVie$581
- Sanofi$546
- plus $2K from 19 others
What the payments were for
- Consulting fees$6,42612%
- Speaking & faculty fees$37,84972%
- Travel & lodging$2,9936%
- Food & beverage$5,07510%
- Education$4901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 23 | $28,580 |
| Janssen Scientific Affairs, LLC | 8 | $11,522 |
| Amgen | 33 | $7,922 |
| Johnson & Johnson | 55 | $1,978 |
| AbbVie | 24 | $581 |
| Sanofi | 18 | $546 |
| Pfizer | 19 | $318 |
| Novartis | 13 | $237 |
| Regeneron Healthcare Solutions, Inc. | 5 | $231 |
| Lilly USA, LLC | 7 | $146 |
| Incyte Corporation | 2 | $141 |
| Smith+Nephew | 6 | $114 |
| LEO Pharma Inc. | 4 | $105 |
| Sun Pharmaceutical Industries Inc. | 4 | $92 |
| Galderma Laboratories, L.p. | 2 | $67 |
| E.r. Squibb & Sons, L.L.C. | 3 | $65 |
| Organogenesis Inc. | 1 | $34 |
| Kyowa Kirin, Inc. | 1 | $25 |
| UCB, Inc. | 1 | $24 |
| Organon | 1 | $20 |
| Biowound Solutions, Inc. | 1 | $19 |
| Dermavant Sciences, Inc. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Oxford Immunotec USA Inc | 1 | $17 |
| Kerecis Limited | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$52,834 in reported general payments places this provider in the 95th percentile of 260 dermatology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $106,447 |
| Dupixent PenDupilumab | 21 | $91,948 |
| Clobetasol Propionate | 251 | $9,723 |
| Fluorouracil | 70 | $5,324 |
| Acitretin | 21 | $3,687 |
| Doxycycline Hyclate | 71 | $2,119 |
| Calcipotriene | 19 | $1,929 |
| Triamcinolone Acetonide | 168 | $1,669 |
| Clindamycin Phosphate | 41 | $1,653 |
| Ketoconazole | 93 | $1,509 |
| Tacrolimus | 14 | $1,285 |
| Doxycycline Monohydrate | 34 | $1,024 |
| Mupirocin | 114 | $849 |
| Metronidazole | 14 | $762 |
| Ciclopirox | 22 | $747 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Stevens Point
- David NelsenJanesville$1.1M
- Gabriela MaloneyOconomowoc$725K
- Kenneth GordonWauwatosa$577K
- Ashley DietrichMilwaukee$466K
- Martin OkunFort Atkinson$232K
- Betsy WernliManitowoc$177K
- Daniel OpelSheboygan$118K
- Stephen LewellisPlover$73K
- Giacomo MaggiolinoKenosha$49K
- Susan KeilerSheboygan$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.